Patient benefit from seamless implant monitoring

  • Karsten Wallbrück
  • Jürgen Schrader
Keywords: cardiac pacing, advanced information technologies, home monitoring

Abstract

Background: Patients with electrostimulation devices visit the hospital regularly for follow-up. The workload of out-patient departments is ever increasing, but a less frequent check-up is unwanted, as it could impair reliability and effectiveness of the therapy. A system of remote patient monitoring might improve this situation by enabling identification of patients who benefit from a shortened time for corrective action after any undesired event. A completely automatic system for patient remote monitoring has been introduced (BIOTRONIK Home Monitoring, HM). Daily patient and device data are displayed on an internet site which allows authorized persons to follow the parameters trends. Several clinical studies are presently being conducted to investigate the benefit of HM in pacemaker and implantable cardioverter/defibrillator therapy. Preliminary results show the system’s ability to individualize implant therapy for the patients’ and the physicians’ benefits. Previous studies in heart failure (HF) therapy have shown that hospital readmission rates, hospitalisation duration and also mortality can be reduced by patient monitoring programs. A recently started study investigating HM in heart failure therapy aims to define a HF-indicator that predicts a worsening of the patient’s status leading to hospitalisation. With such an indicator, the responsible physician could be alerted and the patient can be called in. Although several issues connected to Home Monitoring remain to be solved, the time has come for a more flexible patient management. The incorporation of modern information technology into cardiovascular implants offers a way to solve the conflict between limited resources and high quality medical therapy for an aging population.

Downloads

Download data is not yet available.

References

Scholten MF, Thornton AS, Theuns DA, Res J, Jordaens LJ. Twiddler’s syndrome detected by home monitoring device. Pacing Clin Electrophysiol 2004; 27: 1151–2.ž
Wallbruck K, Stellbrink C, Santini M, Gill J, Hartmann A, Wunderlich E. The value of permanent follow-up of implantable pacemakers – first results of an European trial. Biomed Tech (Berl) 2002; 47 Suppl 1 Pt 2: 950–3.
Varma N, Stambler B, Chun S. Detection of atrial fibrillation by implanted devices with wireless data transmission capability.Pacing Clin Electrophysiol 2005; 28 Suppl 1: S133–6.
Neuser H, Schmidinger H, Kottkamp H, Brugada P, Schumacher B. Automatic remote ICD monitoring facilitates an individualized follow-up in ICD patients. Europace 2004; 6 Suppl. 1: 161. (abstract).
Gonséth J, Guallar-Castillňn P, Benegas JR, Rodrěguez-Artalejo F. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meat-analysis of published reports. Eur Heart J 2004; 25: 1570–95.
Gustafssohn F, Arnold JMO. Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J 2004; 25: 1596–604.
Shah NB, Der E, Ruggerio C, Heidenreich PA, Massie BM. Prevention of hospitalisation for heart failure with an interactive home monitoring program. Am Heart J 1998; 135: 373–8.
Cordisco ME, Beniaminovitz A, Hammond K, Mancini D. Use of telemonitoring to decrease the rate of hospitalisation in patients with severe congestive heart failure. Am J Cardiol 1999; 84: 860–2.
Kievit PC, Verheugt FWA. The Hotline Sessions of the 24th European Congress of Cardiology. Eur Heart J 2003; 24: 2–7.
Middlekauf HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991; 84(1): 40–8.
Madsen BK, Rasmussen V, Hansen JF. Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol 1997; 58: 151–62.
Kadish A, Dyer A, Daubert JP, Quigg R, Mark Estes NA, Anderson KP, et al., for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151–8.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al., for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an Implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 2005; 352: 225–37.
Sauberman RB, Hsu W. Technical performance and clinical benefit of remote monitoring of ICDs. Europace 2004; 6 Suppl 1: 160. (abstract).
Published
2016-09-04
How to Cite
1.
Wallbrück K, Schrader J. Patient benefit from seamless implant monitoring. ZdravVestn [Internet]. 4Sep.2016 [cited 15Dec.2019];74. Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/2190
Section
Test Section